A 67-year-old Japanese man with recurrent nephrotic syndrome and impaired kidney function had a sporadic, elderly-onset case of glomerulopathy with fibronectin deposits. The daily urinary protein, serum albumin, blood urea nitrogen, and creatinine levels were 3.6 g/day, 2.7 g/dL, 19.5 mg/dL, and 1.70 mg/dL, respectively. Kidney biopsy samples were evaluated using electron microscopy and demonstrated membranoproliferative glomerulonephritis-like lesions with massive subendothelial depositions and no fibrillary structures. Immunofluorescent studies showed 1+ staining for IgA, C1q, and fibrinogen. Anti-fibronectin immunostaining demonstrated that the subendothelial deposits were positive for fibronectin. The administration of prednisolone and mizoribine improved the nephrotic syndrome.
Introduction
In 1992, Mazzucco first described glomerulopathy with fibronectin deposits (1) . Subsequently, this hereditary disease has been recognized as a new disease entity (2) . Recently, mutations in the fibronectin 1 (FN1) locus at 2q32 have been reported (3) ; however, such mutations account for only 40% of glomerulopathy with fibronectin deposits (GFND) cases. The pathophysiology, genetic abnormalities, and mechanisms of fibronectin aggregation remain unclear because the incidence of GFND is extremely low. We herein report a sporadic elderly-onset case of GFND and review the literature.
Case Report
A 67-year-old Japanese man was admitted to Aichi Medical University Hospital due to nephrotic syndrome and impaired kidney function. For the 6 years prior to admission, he had been followed by a local physician for hypertension and chronic glomerulonephritis based on his elevated levels of urinary protein (2+), blood urea nitrogen (BUN), (17 mg/ dL), and serum creatinine (1.0 mg/dL). Five years prior to admission, he underwent a kidney biopsy at a local hospital after his 24-hour urinary protein levels increased to 6.0 g and his serum creatinine level increased to 1.3 mg/dL. Light microscopic studies performed at that time demonstrated membranoproliferative glomerulonephritis with massive subendothelial deposits. Unfortunately, immunofluorescent studies were not possible because no glomeruli were present in the specimen. Consequently, 40 mg/day of prednisolone and 150 mg/day of mizoribine, an immunosuppressant used in Japan, were started as a result of the diagnosis of lupuslike lesions with numerous subendothelial deposits based on the electron microscopic studies. At the same time, he was also diagnosed with retinal degeneration. After 2 years, the drugs administered to treat the nephrotic syndrome were dis- continued due to the achievement of complete remission as evidenced by the disappearance of urinary protein. Five months prior to the current admission, the nephrotic syndrome recurred. The patient's kidney function declined as demonstrated by the increasing serum creatinine levels (1.6 mg/dL) despite restarting 40 mg/day of prednisolone and 150 mg/day of mizoribine.
Upon admission, the patient had a normal mental status. His height was 162 cm and his weight was 54 kg. His body temperature was 35.8 , his pulse was 107 beats/min and regular, his respiratory rate was 17 breaths/min, and his blood pressure was 136/88 mmHg. A physical examination revealed a mild edema of the lower extremities. Laboratory studies indicated 3+ proteinuria with no occult blood in the urine and 72 hyaline casts per low power field. The amount of daily urinary protein was 3.6 g. The laboratory results from the blood samples were as follows: white blood cell count (WBC), 6,060/μL; red blood cell count (RBC), 285× 10 4 /μL; hemoglobin, 9.4 g/dL; hematocrit, 27.5%; platelet count, 28. A computed tomography (CT) scan of the chest revealed a 1 cm lesion that was suspicious for thymoma along with multiple cystic lesions in both lungs with emphysematous changes. The abdominal CT scan demonstrated a small lipoma in the right liver and multiple small cysts in both kidneys.
Pathological analysis of the kidney biopsy specimen
No global sclerosis was found in the 16 glomeruli obtained from the kidney biopsy samples. All of the glomeruli exhibited the moderate to severe mesangial cell proliferation (Fig. 1A ) that is associated with massive subendothelial deposits (Fig. 1B, C) , but no crescent formations were identified. Given the absence of any capillary loop double con- tours, these findings resemble membranoproliferative glomerulonephritis (MPGN)-like lesions, and also rule out endocapillary glomerulonephritis, membranous nephropathy, crescentic glomerulonephritis, segmental glomerulosclerosis, and the typical types of mesangial proliferative glomerulonephritis such as IgA nephropathy. Use of electron microscopy revealed massive electron-dense deposits in the subendothelial spaces (Fig. 1D ) without fibrillar structures. Congo red staining was negative. Immunofluorescent studies showed IgA, C1q, and fibrinogen deposition in a band pattern in the subendothelial spaces (Fig. 2) . Using the acquired data, we could not make a final diagnosis for nearly 6 years following this second biopsy.
Several case reports regarding GFND encouraged us to re-analyze this case. We performed immunoassaying using an anti-human fibronectin antibody (PROGEN Biotechnik GmbH, Maaβstrasse 30, D-69123 Heidelberg) and determined that the massive subendothelial deposits contained fibronectin (Fig. 3A-C) .
Clinical course
The amount of daily urinary protein gradually decreased from 3.6 to 1.0 g/day over the next 2 years. After 1 year, the mizoribine treatment was discontinued and the prednisolone treatement course at 2.5 mg/day was continued. Four years after discharge, the patient complained of a persistent cough. A chest CT scan revealed the presence of a 2.0-cm thymoma. A pathological analysis of the surgically removed tumor demonstrated thymic carcinoid. He received 50 Gy (2.0 Gy × 25 doses) of radiation following the surgery. The patient remains in good condition, with 1+ urinary protein, a urine protein to creatinine ratio of 1.43 g/g creatinine, and a serum creatinine level which gradually increased from 1.73 mg/dL to 2.17 mg/dL over 6 years. Recently, the patient underwent surgery to treat gastric cancer. Postoperatively, his urinary protein increased to 3.5 g/day, and albumin levels of 2.5 g/dL were observed. His serum creatinine level was 3.54 mg/dL at 7 years following the second kidney biopsy.
Discussion
There are three unique aspects to the present case. The first is the sporadic, elderly-onset nature of GFND in this patient. The second is the massive subendothelial deposition of fibronectin accompanied by IgA, C1q, and fibrinogen. The third is the response to the prednisolone and mizoribine therapy.
Fibronectin consists of two identical monomers, each with 2,500 amino acid residues (4). There are two types of fibronectin. The first type is a soluble plasma fibronectin, which is a spherical form secreted by the hepatocytes. When this form of fibronectin binds to receptors on the cell surface such as integrin, proteoglycan, and collagen, it transforms into a linear structure that can bind to the other fibronectin molecules to make fibers (5-7). The second type is an insoluble cellular fibronectin, which is secreted from various cells, primarily the fibroblasts, as a soluble dimer. Through a complex process involving cell interactions, this type of fibronectin can be assembled into an insoluble extracellular matrix. Recently, it has been reported that the presence of arginine in the fibronectin molecule plays an important role in fibronectin polymerization (5) . Although GFND is defined as a new disease entity where fibronectin polymer deposits in the glomeruli and several gene mutations have been reported, the critical polymerization of fibronectin is still under investigation. (2, (8) (9) (10) (11) (12) (13) (14) (15) . In 37 of the 44 cases (84%), the onset occurs before the age of 50. There are 7 older patients, including a 59-year-old female, a 64-year-old male and a 53-year-old male in the report from Strøm and colleagues, a 53-year-old male in the report by Uesugi and colleagues, a 75-year-old male in the report by Nadamuni and colleagues, a 52-year-old female who received a renal transplant, and a 67-year-old male in the present study. This case distribution suggests that elderly-onset GFND occurs mainly in males. Further study is needed to clarify the mechanisms underlying the genetic abnormalities, the protein conformational changes and the relationship between abnormal fibronectin and epigenetics. Nephrologists should recognize that some GFND patients may present with elderly-onset nephrotic syndrome in a sporadic fashion.
Regarding the histopathological findings, the present patient had severe mesangial proliferative glomerulonephritis in a lobular form associated with a massive subendothelial deposition. These findings are compatible with MPGN-like lesions. Immunofluorescent studies revealed subendothelial IgA, C1q, and fibrinogen deposition. Such findings may mistakenly lead to a diagnosis of a variant form of lupus nephritis or IgA nephropathy. Shikata et al. previously reported on the co-deposition of fibronectin with IgA in patients with IgA nephropathy; however, the distribution in their patients displayed a mesangial pattern. In the present case, the pathological findings of MPGN-like lesions with massive subendothelial deposits differ from the typical case of mesangial glomerulonephritis with IgA nephropathy (16) .
Following his diagnosis with a variant type of lupus nephritis, the present patient received 40 mg/day of prednisolone and 150 mg/day of mizoribine, an immunosuppressant used in Japan. The most recent kidney biopsy showed the same mesangial pattern, including the massive subendothelial deposition. The deposits were negative with Congo red staining, but strongly positive for fibronectin using enzymelinked antibody methods. These results led to the final diagnosis of GFND. In 15 out of the 43 cases (35%) detailed in Table, glomerular deposition of immunoglobulins, fibrinogen, or complement components were observed. When the patients have lesions consistent with MPGN or MPGN-like lesions, or exhibit mesangial proliferative glomerulonephritis containing a glomerular deposition of IgA or complement components, we must therefore rule out GFND before making a diagnosis of IgA nephropathy or immune complexmediated glomerulonephritis.
A few reports concerning prognosis and therapy were found. Mazzucco et al. reported that 1 out of 2 patients went into complete remission following treatment with indomethacin but the patient was then non-responsive when the nephrotic syndrome recurred (1). Yong et al. reported that 1 patient showed a good response to prednisolone (12) . Br!i ! et al. reported that 1 patient with both nephrotic syndrome and hypertension was stabilized with 2.0 g/day of proteinuria added to a multi-drug regimen (13) . Nadamuni et al. showed that treatment with an angiotensin-converting enzyme inhibitor can decrease the daily amount of urinary protein (14) . A recent study revealed that GFND recurred 1 year after a renal transplant despite treatment with mycophe- The clinical course of the current patient suggests that the initial nephrotic syndrome responded to PSL and mizoribine. Additionally, when nephrotic syndrome recurred, it was responsive to the same drugs. It is unclear as to whether the PSL or the mizoribine was the most effective, or if a combined therapy is needed, or if the improvement reflected the natural course of the disease. Mizoribine has 3 major functions. The first is immunosuppression through the selective inhibition of inosine monophosphate synthetase and guanosine monophosphate synthetase, resulting in a complete inhibition of guanine nucleotide synthesis without incorporation into the nucleotides. The drug arrests DNA synthesis in the S phase of cell division (17) . The second function includes binding to chaperone proteins such as heat shock protein 60 (HSP 60) (18) and 14-3-3 proteins that interact with the glucocorticoid receptor (19) . The third function is the correction of defective nephrin biogenesis through restoring the intracellular energy balance (20) . In addition, the treatment course of the current patient was complicated by the presence of a thymic carcinoid tumor. We did not find any similar complications through an extensive literature review. In the future, it is necessary to study more cases of GFND in order to elucidate the mechanisms of fibronectin polymerization and to find effective treatments.
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